This company may still be operating, however this listing is no longer active. Find out why through their latest events.
Pharma Mar Future Growth
Future criteria checks 3/6
Pharma Mar is forecast to grow earnings and revenue by 26.7% and 5.9% per annum respectively while EPS is expected to grow by 1.3% per annum.
Key information
26.7%
Earnings growth rate
1.33%
EPS growth rate
Biotechs earnings growth
0%
Revenue growth rate
5.9%
Future return on equity
n/a
Analyst coverage
Good
Last updated
05 Jun 2023
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
BMV:PHM1 N - Analysts future estimates and past financials data (EUR Millions)
Date
Revenue
Earnings
Free Cash Flow
Cash from Op
Avg. No. Analysts
12/31/2025
208
58
38
N/A
6
12/31/2024
177
19
6
N/A
6
12/31/2023
165
23
13
N/A
6
3/31/2023
177
29
N/A
N/A
N/A
12/31/2022
196
49
29
38
N/A
9/30/2022
231
84
N/A
N/A
N/A
6/30/2022
233
85
41
48
N/A
3/31/2022
232
91
N/A
N/A
N/A
12/31/2021
230
93
18
26
N/A
9/30/2021
188
63
N/A
N/A
N/A
6/30/2021
200
67
19
24
N/A
3/31/2021
222
91
113
117
N/A
12/31/2020
270
137
276
279
N/A
9/30/2020
246
147
264
270
N/A
6/30/2020
214
124
255
259
N/A
3/31/2020
166
72
161
165
N/A
12/31/2019
86
-9
-28
-24
N/A
9/30/2019
136
-27
-24
-23
N/A
6/30/2019
84
-37
-12
-12
N/A
3/31/2019
154
-24
-24
-22
N/A
12/31/2018
109
-17
-19
-17
N/A
9/30/2018
189
-16
-23
-20
N/A
6/30/2018
128
-20
-27
-22
N/A
3/31/2018
179
-26
-24
-19
N/A
12/31/2017
159
-28
-6
-1
N/A
9/30/2017
182
-22
-1
4
N/A
6/30/2017
186
-18
3
9
N/A
3/31/2017
184
-19
7
13
N/A
12/31/2016
181
-24
N/A
-8
N/A
9/30/2016
187
-18
N/A
N/A
N/A
6/30/2016
188
-10
N/A
5
N/A
3/31/2016
190
-7
N/A
N/A
N/A
12/31/2015
194
7
N/A
11
N/A
12/31/2014
175
13
N/A
23
N/A
12/31/2013
74
12
N/A
74
N/A
12/31/2012
66
10
N/A
67
N/A
Analyst Future Growth Forecasts
Earnings vs Savings Rate: PHM1 N's forecast earnings growth (26.7% per year) is above the savings rate (7.6%).
Earnings vs Market: PHM1 N's earnings (26.7% per year) are forecast to grow faster than the MX market (9.2% per year).
High Growth Earnings: PHM1 N's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: PHM1 N's revenue (5.9% per year) is forecast to grow slower than the MX market (6.2% per year).
High Growth Revenue: PHM1 N's revenue (5.9% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if PHM1 N's Return on Equity is forecast to be high in 3 years time
Discover growth companies
7D
1Y
7D
1Y
7D
1Y
Company Analysis and Financial Data Status
Data
Last Updated (UTC time)
Company Analysis
2023/06/12 01:11
End of Day Share Price
2023/03/16 00:00
Earnings
2023/03/31
Annual Earnings
2022/12/31
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Pharma Mar, S.A. is covered by 12 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.